AzTrials
AzTrials

Aneurysm, IntracranialNCT03117803

The Natural Course of Unruptured Intracranial Aneurysms in a Chinese Cohort

An observational study of Aneurysm, Intracranial and Natural History, run by Tang-Du Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a registry study of the natural course of unruptured intracranial aneurysms (UIA). In addition, the investigators will analyze the risk factors for the rupture of the UIA and their joint effect. The investigators aim to use research data to create a China national database of UIA. Read more about this study

Who is it for?
Ages 14 years and older
Conditions the study is for
Aneurysm, Intracranial, Natural History
How many people
5,000 participants
Where
1 siteChina
Study dates
1 May 2017to 30 Dec 2021
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The patients who diagnosed as unruptured intracranial aneurysms

Who may be able to join

  • Diagnosis of untreated unruptured intracranial aneurysm (by CTA, MRA or DSA)
  • Patient with premorbid mRS of 3 or less.
  • Patient older than 18 years
  • Patient consenting to participate to the study

Who cannot join

  • Subarachnoid hemorrhage with unknown causes
  • Patient with other cerebral arteriovenous malformations or cerebral arteriovenous fistulas
  • Patient with malignant tumor
  • Target aneurysm is fusiform, traumatic, mycotic, or dissecting related.
  • Inability to obtain informed consent.
  • Patients with a life expectancy less than 1 year
  • Participating in the other clinical studies of intracranial aneurysm
  • Refusal of follow-up

Trial locations and contacts

1 site in 1 country.

Wei Guo, M.D, Ph.D contact

86-18729985168

18729985168@163.com

Haixiao Liu, M.D contact

86-15929315407

56761311@qq.com

China1 site, 1 recruiting
  • Tandu Hospital, Fourth Military Medical University

    Xi'an, Shaanxi, 710038

    Wei Guo, M.D Ph.D, 86-18729985168, 18729985168@163.com

    Haixiao Liu, M.D, 86-15929315407, 56761311@qq.com

    Recruiting

Other trials in China

About this study

This is a registry study of the natural course of unruptured intracranial aneurysms (UIA). In addition, the investigators will analyze the risk factors for the rupture of the UIA and their joint effect. The investigators aim to use research data to create a China national database of UIA.

Read the detailed description

This is a registry study of the natural course of unruptured intracranial aneurysms (UIA). In addition, the investigators will analyze the risk factors for the rupture of the UIA and their joint effect. The investigators aim to use research data to create a China national database of UIA.

This study is supported by a research grant from the Ministry of Science and Technology of the People's Republic of China. The investigators will collaborate with the other 19 medical centers which locate in the different districts of China. During the study period, all the patients included in this study will observe and treat in the collaborating medical centers. Included patients will be followed-up for at least 1year.

Research data will represent the real natural course of UIA in China.

For this study, the investigators consulted and hired professional experts about data collection, data and methodology. An intact systematic project steering committee, including Data Monitoring Committee, Data Management Committee, Project Academic Committee, Executive Group, Project Manager, Project Statistician, and Technical Support Center has been built up. Scientific regulations have also been made.

Keywords
Aneurysm, Intracranial, Registries, Multicenter Studies, People's Republic of China
Medical subject headings
Intracranial Aneurysm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. aneurysm rupture rate

    aneurysm rupture rate

    Measured: Up to 4 years or time of aneurysm repair surgery

Secondary outcomes (1)
  1. Morphological changes of aneurysms

    maximum diameter increase ≥ 1mm or appearance of a daughter sac

    Measured: Up to 4 years or time of aneurysm repair surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2017
  2. Study start1 May 2017
  3. Primary completion30 Dec 2020 (estimated)
  4. Study completion30 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
5,000 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT03117803
Sponsor's protocol ID
2016YFC1300801
Status last verified
Apr 2017
First submitted
4 Apr 2017
Last updated
5 Jul 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: share the original data 5 years after the study completion

Publications

  • International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms--risk of rupture and risks of surgical intervention. N Engl J Med. 1998 Dec 10;339(24):1725-33. doi: 10.1056/NEJM199812103392401.

    PubMed 9867550
  • Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003 Jul 12;362(9378):103-10. doi: 10.1016/s0140-6736(03)13860-3.

    PubMed 12867109
  • UCAS Japan Investigators; Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, Hashimoto N, Nakayama T, Sakai M, Teramoto A, Tominari S, Yoshimoto T. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012 Jun 28;366(26):2474-82. doi: 10.1056/NEJMoa1113260.

    PubMed 22738097
  • Liu H, Guo W, Xiang S, Hu P, Sun F, Gao J, Zhang X, Wang P, Jing W, Zhang L, Yang X, Duan C, He M, Zhang H, Qu Y. The natural course of unruptured intracranial aneurysms in a Chinese cohort: protocol of a multi-center registration study in CIAP. J Transl Med. 2019 Oct 22;17(1):349. doi: 10.1186/s12967-019-2092-z.

    PubMed 31640726

Questions about this trial

What is this clinical trial studying?

An observational study of Aneurysm, Intracranial and Natural History, run by Tang-Du Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Wei Guo, M.D, Ph.D (86-18729985168, 18729985168@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

aneurysm rupture rate (time frame: Up to 4 years or time of aneurysm repair surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03117803, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in